State Street Corporation »

Revance Therapeutics shares owned by State Street Corporation

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by State Street Corporation from 13F filings

Historical chart of State Street Corporation investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by State Street Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by State Street Corporation

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.9M 2.3M 2.57
2024-03-31 $12M 2.4M 4.92
2023-12-31 $22M 2.5M 8.79
2023-09-30 $27M 2.3M 11.47
2023-06-30 $52M 2.1M 25.31
2023-03-31 $63M 1.9M 32.21
2022-12-31 $38M 2.0M 18.46
2022-09-30 $44M 1.6M 27.00
2022-06-30 $25M 1.8M 13.82
2022-03-31 $30M 1.5M 19.50
2021-12-31 $26M 1.6M 16.32
2021-09-30 $42M 1.5M 27.86
2021-06-30 $43M 1.4M 29.64
2021-03-31 $38M 1.4M 27.95
2020-12-31 $42M 1.5M 28.34
2020-09-30 $34M 1.3M 25.14
2020-06-30 $33M 1.4M 24.42
2020-03-31 $17M 1.2M 14.80
2019-12-31 $17M 1.1M 16.23
2019-03-31 $13M 813k 15.76
2018-12-31 $14M 676k 20.13
2018-09-30 $18M 720k 24.85
2018-06-30 $18M 669k 27.45
2018-03-31 $18M 593k 30.80
2017-12-31 $17M 461k 35.74
2017-09-30 $13M 466k 27.55
2017-06-30 $12M 453k 26.40
2017-03-31 $9.4M 450k 20.80
2016-12-31 $6.7M 325k 20.70
2016-09-30 $5.0M 308k 16.22
2016-06-30 $5.8M 430k 13.60
2016-03-31 $9.2M 527k 17.46
2015-12-31 $13M 389k 34.16
2015-09-30 $6.7M 226k 29.78
2015-06-30 $6.2M 193k 32.01
2015-03-31 $2.3M 111k 20.71
2014-12-31 $1.8M 104k 16.93
2014-09-30 $1.9M 99k 19.36
2014-06-30 $3.1M 91k 34.01
2014-03-31 $2.1M 66k 31.50